Home MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO (fluralaner) Spot-On for Cats and Dogs
 

Keywords :   


MSD Animal Health Receives Positive Final Opinion from European Medicines Agency for BRAVECTO (fluralaner) Spot-On for Cats and Dogs

2016-03-22 09:00:00| Merck.com - Corporate News

Dateline City: MADISON, N.J. Only Spot-On Treatment for Fleas and Ticks Effective For 12 Weeks MADISON, N.J.--(BUSINESS WIRE)--MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced that the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency has adopted a positive final opinion, recommending the granting of a marketing authorization for the veterinary medicinal product BRAVECTO (fluralaner) Spot-On for both cats and dogs. Language: English Contact: MSD Animal HealthMedia:Amy Firsching, +1-908-473-6357amy.firsching@merck.comorPam Eisele, +1-908-423-5042pamela_eisele@merck.com Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: health final positive opinion

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
24.11STEINBACH40
24.11 Sepua Crue F-170
24.11 SECRET
24.11CRAwith
24.1111/15)&&
24.11 8
24.11
24.11F2023 23
More »